Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls

BACKGROUND: Familial adenomatous polyposis (FAP) is a disease characterized by the development of hundreds to thousands of adenomatous polyps in the colorectum early in life. Virtually all patients with FAP will develop colorectal cancer before the age of 40 to 50 years, unless prophylactic colectom...

Descripción completa

Detalles Bibliográficos
Autores principales: van Heumen, Bjorn WH, Roelofs, Hennie MJ, te Morsche, René HM, Nagengast, Fokko M, Peters, Wilbert HM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225600/
https://www.ncbi.nlm.nih.gov/pubmed/24245549
http://dx.doi.org/10.1186/1750-1172-8-181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225600/
https://www.ncbi.nlm.nih.gov/pubmed/24245549
http://dx.doi.org/10.1186/1750-1172-8-181

Ejemplares similares